Live
- Over 7,600 Syrians return from Turkiye in five days after Assad's downfall: minister
- Delhi BJP leaders stay overnight in 1,194 slum clusters
- Keerthy Suresh and Anthony Thattil Tie the Knot in a Christian Ceremony
- AAP, BJP making false promises to slum dwellers for votes: Delhi Congress
- 'Vere Level Office' Review: A Refreshing Take on Corporate Life with Humor and Heart
- Libya's oil company declares force majeure at key refinery following clashes
- Illegal Rohingyas: BJP seeks Assembly session to implement NRC in Delhi
- Philippines orders full evacuation amid possible volcanic re-eruption
- Government Prioritizes Welfare of the Poor, says Dola Sri Bala Veeranjaneyaswamy
- Two Russian oil tankers with 29 on board damaged due to bad weather
300 million doses of Covid vaccine ready by Dec: Serum Institute of India
Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December
New Delhi: Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December.
With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential vaccine will be ready by December.
In an interview to India Today, Poonawalla said, "Each dose has 10 vials and Covishield is going to be the first Covid-19 vaccine we hope to launch if trials are successful in the UK and India."
He said that they expect the vaccine to reach the people of India in large numbers by the first quarter of 2021. The vaccine will cost around Rs 1,000 in India, he added.
